Daiken Medical Co., Ltd.

Tokyo Stock Exchange 7775.T

Daiken Medical Co., Ltd. Debt to Equity Ratio for the year ending March 31, 2024: 0.30

Daiken Medical Co., Ltd. Debt to Equity Ratio is 0.30 for the year ending March 31, 2024, a -26.86% change year over year. Debt to equity ratio represents the financing from debt versus equity. Higher ratio indicates more debt reliance, suggesting potential risk.
  • Daiken Medical Co., Ltd. Debt to Equity Ratio for the year ending March 31, 2023 was 0.41, a -9.02% change year over year.
  • Daiken Medical Co., Ltd. Debt to Equity Ratio for the year ending March 31, 2022 was 0.45, a -5.21% change year over year.
  • Daiken Medical Co., Ltd. Debt to Equity Ratio for the year ending March 31, 2021 was 0.48, a -0.40% change year over year.
  • Daiken Medical Co., Ltd. Debt to Equity Ratio for the year ending March 31, 2020 was 0.48, a -19.76% change year over year.
Key data
Date Debt to Equity Ratio Debt to Income Ratio Debt to Tangible Net Worth Ratio Dividend Coverage Ratio
Market news
Tokyo Stock Exchange: 7775.T

Daiken Medical Co., Ltd.

CEO Mr. Keiichi Yamada
IPO Date March 12, 2009
Location Japan
Headquarters 2-6-2, Ayumino
Employees 175
Sector Health Care
Industries
Medical Instruments Pharmaceuticals
Description

Daiken Medical Co., Ltd. manufactures and distributes medical devices and equipment in Japan and internationally. The company offers syringe pumps, disposable infusion pumps, portable disposable infusers, endobronchial blocker tubes, suction containers, connecting tubes, suction tips, medical hand washing machines, disposable medical towels, sterilize mats, and wet disinfectant mats. It also trades in medical equipment. The company sells its products under the COOPDECH brand. Daiken Medical Co., Ltd. was incorporated in 1968 and is headquartered in Izumi, Japan.

StockViz Staff

January 16, 2025

Any question? Send us an email